DDX5 inhibits inflammation by modulating m6A levels of TLR2/4 transcripts during bacterial infection

Jian Xu,Li-Yuan Liu,Fei-Jie Zhi,Yin-Juan Song,Zi-Hui Zhang,Bin Li,Fu-Ying Zheng,Peng-Cheng Gao,Su-Zi Zhang,Yu-Yu Zhang,Ying Zhang,Ying Qiu,Bo Jiang,Yong-Qing Li,Chen Peng,Yue-Feng Chu
DOI: https://doi.org/10.1038/s44319-023-00047-9
IF: 9.071
2024-01-05
EMBO Reports
Abstract:Abstract DExD/H-box helicases are crucial regulators of RNA metabolism and antiviral innate immune responses; however, their role in bacteria-induced inflammation remains unclear. Here, we report that DDX5 interacts with METTL3 and METTL14 to form an m6A writing complex, which adds N6-methyladenosine to transcripts of toll-like receptor (TLR) 2 and TLR4, promoting their decay via YTHDF2-mediated RNA degradation, resulting in reduced expression of TLR2/4. Upon bacterial infection, DDX5 is recruited to Hrd1 at the endoplasmic reticulum in an MyD88-dependent manner and is degraded by the ubiquitin-proteasome pathway. This process disrupts the DDX5 m6A writing complex and halts m6A modification as well as degradation of TLR2/4 mRNAs, thereby promoting the expression of TLR2 and TLR4 and downstream NF-κB activation. The role of DDX5 in regulating inflammation is also validated in vivo, as DDX5- and METTL3-KO mice exhibit enhanced expression of inflammatory cytokines. Our findings show that DDX5 acts as a molecular switch to regulate inflammation during bacterial infection and shed light on mechanisms of quiescent inflammation during homeostasis.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?